No Data
No Data
Asian Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday Trading
Zai Lab Management to Meet With Cantor Fitzgerald
Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024
Novocure Gets FDA Approval for Its Lung Cancer Treatment
Jefferies Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $38
Jefferies Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $38
No Data
No Data